News for PRAH Stock

Veradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research Network PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma PRA Health Sciences, Inc. Reports First Quarter 2021 Results PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth services PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance PRA Health Sciences to Report Third Quarter 2020 Earnings PRA Health Sciences selected by BARDA to be a member of its exclusive Clinical Studies Network PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials PRA Health Sciences Announces Appointment of New Director PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia PRA Health Sciences to Report Second Quarter 2020 Earnings PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology